# ðŸŽ¯ WIWFM FOR SPORADIC - EFFICACY PREDICTION

---

## **INPUTS**

- `germline_status`: "negative" | "positive" | "unknown"
- `tumor_context` (when germline negative):
  - `somatic_mutations[]`
  - `tmb`, `msi_status`, `hrd_score`
  - `copy_number_alterations[]`
- `treatment_history`
- `options` (profile flags)

---

## **SCORING (S/P/E + SAE + LINES)**

### **Sequence (S)**:
- Score somatic mutations with Evo2
- Merge with CNAs (e.g., ERBB2 amp)

### **Pathway (P)**:
- Aggregate multi-hit disruptions
- Weight by disease + line

### **Evidence (E)**:
- Prefer tumor-based literature
- Apply badges (Guideline/Label/PathwayAligned)

### **SAE Features**:
- TMB, MSI, HRD, amplifications, losses
- Lift drug classes (checkpoint for TMB-high)

### **Treatment Lines**:
- `line_appropriateness`, `cross_resistance_risk`, `sequencing_fitness`

### **Germline Gating**:
- If germline negative + no HRD â†’ penalize PARP
- If TMB â‰¥10-15 or MSI-high â†’ boost checkpoint

---

## **OUTPUT**

`drugs[*]`: efficacy_score, confidence, evidence_tier, sae_features, treatment_line, rationale, provenance

---

**NEXT**: Read `10_AYESHA_CASE_STUDY.mdc`
